ST3GAL5 and hepatocellular carcinoma: In addition, miR-26a, miR-548l, and miR-34a have been reported to inhibit the expression of ST3GAL5, which encodes Lactosylceramide alpha-2,3-sialyltransferase, to suppress HCC cell proliferation and migration [51].